Background: Venous thromboembolism (VTE) causes major morbidity in adults after trauma, occurring in up to 50% of patients without prophylaxis. The incidence of VTE after trauma is lower in children. No study has measured the incidence of and risk factors for VTE in critically ill children after trauma. Methods: Nested case-control study of children, younger than 18 years, admitted to the pediatric intensive care unit at a level I trauma center. Three controls were selected for each identified VTE case. Results: Nine of 144 children admitted to the pediatric intensive care unit after trauma developed VTE (incidence 6.2%, 95% confidence interval [CI] 2.3-10.2), with a median age of 8.6 years (range, 2.3-17.9). VTE was diagnosed at a median of 9 days after admission, with 67% of VTE located at the site of previous or existing central venous line (CVL). Significant risk factors for thrombosis included parenteral nutrition (odds ratio [OR] 20, 95% CI 1.9 -227), CVL (OR 19, 95% CI 2-178), deep sedation (OR 13, 95% CI 1.6 -48), neuromuscular blockade (OR 10, 95% CI 1.4 -70), inotropic support (OR 10, 95% CI 1.7-59), and recombinant factor VIIa administration (p ϭ 0.012, OR not calculable). Logistic analysis found a 7.9-fold increase in the odds of developing VTE for each additional CVL (p ϭ 0.005), a threefold increase with each additional risk factor present (p ϭ 0.009), and a 1.3-fold increase for an increase in injury severity (p ϭ 0.03). VTE was not associated with sepsis, spinal cord injury, fracture, or elevated D-dimer level. Conclusions: VTE is not a rare event in critically ill children after trauma. Most patients developing thrombosis have multiple risk factors, including poor perfusion, immobility, and presence of a CVL.
V enous thromboembolism (VTE) causes major morbidity in the adult trauma population, occurring in 20% to 50% of patients in the absence of thromboprophylaxis. 1, 2 Studies in children treated for trauma have shown a much lower incidence of VTE, in the range of 0.05% to 0.33%. [3] [4] [5] [6] [7] Older age, increased injury severity, and the presence of a central venous line (CVL) have been identified as risk factors for VTE in children after trauma. 4 -6,8 Children admitted to a pediatric intensive care unit (PICU) after severe trauma are more likely to have these risk factors and may have a higher incidence of VTE than that reported for the general pediatric population after varying degrees of traumatic injury. Because of the presence of multiple risk factors in critically ill patients, there may be specific subgroups of patients admitted to the PICU after trauma who would benefit from VTE prophylaxis or active screening for VTE.
In this study, we prospectively measured the incidence of and the risk factors for developing VTE in children admitted to a PICU after traumatic injury.
MATERIALS AND METHODS

Subjects
The Children's Hospital of Wisconsin (CHW) institutional review board approved this nested case-control study. Since April 1, 2006 , as part of a Quality Improvement PICU Thrombosis Database Project, all children admitted to the PICU of the Children's Hospital of Wisconsin were followed up prospectively for the development of clinically apparent VTE: reviewing all medication, nursing, radiology, and consults orders; all laboratory results; all diagnostic imaging, such as computed tomography, magnetic resonance imaging, angiograms or ultrasonography of head, chest, heart, abdomen, pelvis or extremity; and all procedural or surgical notes. In addition, the critical care team was queried weekly regarding patients who develop VTE. There was no surveillance imaging for VTE as part of this study.
From this database, all patients younger than 18 years of age, admitted April 1, 2006 , to June 30, 2007, for management of traumatic injuries, were identified as cases for this study. The controls selected for each case were identified as the next three sequential patients listed in the trauma registry admitted to the PICU who were not in the Quality Improvement PICU Thrombosis Database. The total number of children admitted to the PICU after trauma during the study period was obtained from the trauma registry.
Data Collection
Demographics, measures of trauma severity, physiologic instability, and interventions were collected from admission to the time of VTE diagnosis for each of the cases. For the control group, the same data were collected for the same amount of time; that is if the case developed VTE on hospital day 6, the matched controls had data collected for 6 days (a surrogate VTE date) or until hospital discharge, whichever occurred earlier.
Variables collected included Trauma Score (RTS), and Pediatric Trauma Score (PTS). [10] [11] [12] The Injury Severity Score is an anatomic scoring system ranging 0 to 75, with the higher number indicating increased injury severity. The raw RTS is a physiologic scoring system ranging 0 to 12, using variables such as the Glasgow Coma Score, systolic blood pressure, and respiratory rate. In this score, the lower number is more injured. The PTS is a physiologic scoring system ranging Ϫ6 to 12 developed for children after trauma. The lower is the score the more severely injured is the child.
Statistical Analysis
The incidence of VTE was calculated as the number of cases of VTE/total trauma admissions to the PICU. Nonparametric data are presented as median (range). For continuous variables, box-plots and nonparametric tests were used to compare the medians of the values between the case and control group. Chi-square and Fischer's exact tests for dichotomous variables were used to compare percentages between case and control groups. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for each categorical risk factor for VTE, and binomial logistic regression was used to calculate the odds of thrombosis associated with continuous variables. Analysis was performed using SPSS, version 16.0 (SPSS, Chicago, IL).
RESULTS
Between April 1, 2006, and June 30, 2007, nine cases of VTE were identified in 144 children admitted to the PICU after trauma (incidence 6.2%, 95% CI 2.3-10.2). This was a significantly higher rate of VTE (p ϭ 0.002) compared with the 41 cases of VTE in the 1966 nontrauma admissions to the PICU for the same time period (incidence 2.1%, 95% CI 1.5-2.7).
The case and control groups did not differ in age, sex, weight, prophylactic anticoagulation, or mortality ( Table 1) . The cases had more severe injury based on raw RTS and PTS and had longer hospital stay. Table 2 summarizes the characteristics of the cases of VTE. There was one pulmonary embolus (PE) after open reduction of a femur fracture; however, associated deep vein thrombosis was never identified in this patient. Most clots were located in lower extremity blood vessels. Many patients had comorbidities: cases 5 and 6 had both culture-positive bacteremia and, at a different time, culture-negative physician-diagnosed sepsis. Case 3 was on oral contraceptives before admission. Case 2 had a femur fracture in addition to the spinal cord injury.
Eight of the nine cases of VTE had a CVL placed before diagnosis of VTE, and six of nine (67%) developed VTE at the site of the CVL: four (44%) at a previous CVL site and two (22%) at a current CVL site. These clots were not always apparent early in the hospital course (median diagnosis was on hospital day 9). Three patients were diagnosed with VTE on the wards after discharge from the PICU.
Comparison of interventions and complications between cases and controls is shown in Table 3 . Significant risk factors for thrombosis included TPN (OR 20, 95% CI 1.9 - Increasing number of risk factors was associated with increased risk of VTE. The cases had a median of 4 risk factors compared with the control group with a median of 0 risk factors (p Ͻ 0.0001, Fig. 1 ). The odds of thrombosis ECMO, extracorporeal membrane oxygenation; VAD, ventricular assist device; CPR, chest compressions Ͼ5 min; SPO 2 , pulse oximetry oxygen saturation; rSO 2 , regional somatic oxygen saturation; Nmb, neuromuscular blockade; GCS, Glasgow Coma Score; SIRS, systemic inflammatory response syndrome.
increased threefold for each additional risk present (p ϭ 0.009). There was a 7.9-fold increase in the odds of developing VTE for each additional CVL (p ϭ 0.005).
Follow-up after discharge was available in seven of nine cases. All seven cases were anticoagulated for 6 weeks to 1 year. Anticoagulation was stopped with either clot resolution or chronic stability with vessel recanalization. One patient reported occasional calf pain at 6 months, and two cases had minimal extremity swelling with no pain at 6 months and 1 year after VTE. None of the seven cases had decreased function.
DISCUSSION
In this study of critically ill children after trauma, the rate of symptomatic VTE (6.2%) was higher than those previously reported for children after trauma, 0.05% to 0.3%. 4 -8 We identified the presence of CVL, TPN, deep sedation, neuromuscular blockade, inotropic support, and recombinant factor VIIa to be associated with a high risk of thrombosis. Previous studies in children after trauma included general pediatric patients with varying degree of traumatic injury. This study looked specifically at children admitted to the PICU, which may account for the higher rate of VTE, 6.2%, in our study. It is not surprising that critical illness after trauma increases the risk for VTE, even in children. Direct endothelial disruption, hypercoagulability from inflammation, and venous stasis from decreased mobility promote clot formation in trauma patients. In addition, the sickest patients may have hypotension and decreased cardiac output, resulting in more prolonged venous stasis and inflammation. They may acquire infections resulting in increased inflammation, CVLs resulting in additional blood vessel endothelial damage, and procoagulant pharmacologic support resulting in further hypercoagulability.
Pediatric studies using active imaging for asymptomatic VTE found higher CVL-associated VTE rates: 8% to 35%. 13, 14 In contrast, our study captured only symptomatic VTE, where imaging for VTE was directed by the clinical team. VTE evaluation may have been deferred in patients who were unstable or progressing to brain death. The rate of VTE detected by surveillance imaging would be expected to be even higher, with the ratio of asymptomatic to symptomatic VTE estimated as 5:1 to 10:1. 1 In our study, the most common symptoms prompting investigation for VTE were limb swelling, erythema, or venous congestion.
Laboratory values, including D-dimers and platelet count, were not discerning for VTE in this critically ill population. Just before clot diagnosis, the median D-dimer level was elevated to 660 ng/mL (141-1660) for cases and 700 ng/mL (100 -2500) for the control group (p ϭ 0.70), with a median platelet count of 245K/L (79 -586) for cases and 263K/L (32-655) for the control group. This is consistent with the findings of previous studies that D-dimer elevation is a nonspecific marker of inflammation and coagulopathy in critically ill patients. 15, 16 In addition, D-dimers were elevated in only two of three children with thrombosis. 17 This study is the first pediatric study to report on the relatively late time to clot diagnosis, with a median time of 9 days after admission. This may represent a delay in clot development or a delay in diagnosis. If the delay in diagnosis is due to late development of VTE, there may be a benefit in initiating VTE prophylaxis for these high-risk children after the initial period of bleeding has resolved.
Studies with a small number of clots (2-11 VTE during 3.5-9 years 4, 5, 7, 8 ) have identified both increased injury severity and older age as risk factors for VTE in children after trauma. A larger, retrospective study of 45 children with a trauma-related diagnosis and an International Classification of Diseases, 9th revision, discharge diagnosis of VTE, in 19 states in 1 year, 6 found that increasing injury severity and presence of CVL were associated with VTE. Increased injury severity and presence of CVL were confirmed as significant risk factors in our study. Six (66%) clots were found in children younger than 13 years, illustrating that even younger children are at risk for thrombosis after trauma, given sufficient risk factors (Fig. 2) . Additional risk factors for VTE, not previously identified in children after trauma, are the use of TPN, deep sedation, neuromuscular blockade, inotropes, and recombinant factor VIIa administration. These variables frequently require administration through a CVL. Theoretically, low flow states (inotropic use), stasis (deep sedation, neuromuscular blockade), and hypercoagulability (TPN, factor VIIa) may be independent variables of increased thrombotic risk. A larger study will be needed to separate these covariate effects. However, it is likely that the simultaneous occurrence of several of these factors is what increases the risk of VTE in this population. Indeed, we found a median of 4 of these risk factors in cases of VTE and a median of 0 in controls.
Other risk factors, such as sepsis/systemic inflammatory response syndrome, did not reach significance in this study, however, the small number of cases leads to a higher likelihood of type II error, and some of these risks may associate with thrombosis in larger studies. In addition, the limited sample size results in wide confidence intervals, as shown in Table 3 .
Risk factors were collected up until the time of the clot diagnosis. It is possible that some of the perfusion factors, such as shock, CPR, extracorporeal membrane oxygenation, could be manifestations of massive VTE rather than a risk for developing VTE. The two patients in this study receiving CPR, one of whom required cardiopulmonary bypass, did so in the trauma room because of cardiopulmonary arrest from hemorrhagic and cardiogenic shock from thoracic gunshot wounds. It is true that massive PE can present with similar symptoms and require similar resuscitation; however, the timing immediately after massive trauma makes this scenario less likely. Only one patient with PE did not have perfusion risk factors that are listed above. Therefore, although the study assumes a temporal association of risk factors contributing to clot, this seems to be valid by examination of the individual cases.
This study is limited to a single tertiary care pediatric trauma center during a 15-month study period. A multicenter study is needed to confirm the incidence and risk factors for VTE found in this study. This will be difficult to replicate at our institution because local presentation of these results has triggered increased VTE prophylaxis with enoxaparin for children admitted to the PICU after trauma. The identification of a subgroup of children at high risk for VTE leads to need for evaluation of preventive therapy. Because many patients in this study were symptomatic for thrombosis later in their hospital stay, there may be a window for effective prophylactic anticoagulation to start after the initial bleeding risk has diminished. These data form the basis for future work evaluating the efficacy of VTE prophylaxis in decreasing the incidence of thrombosis in critically ill children after trauma.
CONCLUSIONS
VTE is not rare in critically ill children after trauma. Most children who develop VTE have multiple risk factors, including the presence of a CVL, poor perfusion, and immobility. This highest risk pediatric population, especially those with multiple risk factors, may benefit from VTE prophylaxis.
